Nutriband Financial Statements From 2010 to 2025

NTRB Stock  USD 6.57  0.37  5.97%   
Nutriband financial statements provide useful quarterly and yearly information to potential Nutriband investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Nutriband financial statements helps investors assess Nutriband's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Nutriband's valuation are summarized below:
Nutriband does not presently have any fundamental ratios for analysis.
Check Nutriband financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Nutriband's main balance sheet or income statement drivers, such as , as well as many indicators such as . Nutriband financial statements analysis is a perfect complement when working with Nutriband Valuation or Volatility modules.
  
Check out the analysis of Nutriband Correlation against competitors.
For information on how to trade Nutriband Stock refer to our How to Trade Nutriband Stock guide.

Nutriband Company Return On Equity Analysis

Nutriband's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.

Return On Equity

 = 

Net Income

Total Equity

More About Return On Equity | All Equity Analysis

Current Nutriband Return On Equity

    
  -0.6  
Most of Nutriband's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Nutriband is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
Competition

Based on the latest financial disclosure, Nutriband has a Return On Equity of -0.6041. This is 97.48% lower than that of the Biotechnology sector and 98.34% lower than that of the Health Care industry. The return on equity for all United States stocks is 94.87% higher than that of the company.

Nutriband Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Nutriband's current stock value. Our valuation model uses many indicators to compare Nutriband value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Nutriband competition to find correlations between indicators driving Nutriband's intrinsic value. More Info.
Nutriband is regarded fifth in return on equity category among its peers. It is rated below average in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Nutriband's earnings, one of the primary drivers of an investment's value.

About Nutriband Financial Statements

Nutriband stakeholders use historical fundamental indicators, such as Nutriband's revenue or net income, to determine how well the company is positioned to perform in the future. Although Nutriband investors may analyze each financial statement separately, they are all interrelated. For example, changes in Nutriband's assets and liabilities are reflected in the revenues and expenses on Nutriband's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Nutriband. Please read more on our technical analysis and fundamental analysis pages.
Nutriband Inc. develops a portfolio of transdermal pharmaceutical products. The company was incorporated in 2016 and is headquartered in Orlando, Florida. Nutriband operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 13 people.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Nutriband offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Nutriband's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Nutriband Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Nutriband Stock:
Check out the analysis of Nutriband Correlation against competitors.
For information on how to trade Nutriband Stock refer to our How to Trade Nutriband Stock guide.
You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Nutriband. If investors know Nutriband will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Nutriband listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Nutriband is measured differently than its book value, which is the value of Nutriband that is recorded on the company's balance sheet. Investors also form their own opinion of Nutriband's value that differs from its market value or its book value, called intrinsic value, which is Nutriband's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Nutriband's market value can be influenced by many factors that don't directly affect Nutriband's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Nutriband's value and its price as these two are different measures arrived at by different means. Investors typically determine if Nutriband is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Nutriband's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.